Idelalisib ‐rituximab induces durable remissions in TP53 disrupted B‐PLL but results in significant toxicity: updated results of the UK‐wide compassionate use programme

Source: British Journal of Haematology - Category: Hematology Authors: Tags: Correspondence Source Type: research